Results

Sumitomo Dainippon Pharma Co. Ltd.

05/09/2022 | Press release | Distributed by Public on 05/08/2022 17:39

Myovant Sciences and Pfizer Provide Update on sNDA for MYFEMBREE for the Management of Moderate to Severe Pain Associated With Endometriosis